Red Light Therapy for Diabetic Foot Ulcers: RCT and Meta-Analysis Evidence Reviewed

Diabetic foot ulcers are slow, dangerous wounds that send hundreds of thousands of people to the hospital each year and lead the list of causes for non-traumatic lower-limb amputation. Red and near-infrared light therapy, also called photobiomodulation (PBM) or low-level laser therapy (LLLT), has been studied for years as a way to speed these wounds toward closure. This review walks through what the randomized trials and meta-analyses actually show, where the evidence is genuinely promising, and where it is weak enough that no honest reading can call it proven.

What a Diabetic Foot Ulcer Is and Why It Is So Hard to Heal

A diabetic foot ulcer (DFU) is an open sore, usually on the bottom of the foot or over a pressure point, that develops in someone with diabetes. Three problems stack up to cause it. High blood sugar over years damages nerves, so the person cannot feel the rubbing or pressure that creates the wound. The same disease narrows and stiffens blood vessels, so less oxygen-rich blood reaches the foot. And high glucose blunts the immune cells that fight infection and the fibroblasts that rebuild tissue.

The result is a wound that a healthy person would close in two weeks but that can stay open for months. About a third of these ulcers never heal with standard care alone, and a non-healing ulcer is the most common path to amputation. That is why DFUs are treated as a serious medical problem, not a cosmetic one, and why any add-on therapy gets measured against a high bar.

Standard of care is well defined and is the foundation every study builds on. The International Working Group on the Diabetic Foot (IWGDF) calls for pressure offloading with a total contact cast or non-removable walker, regular debridement of dead tissue, infection control, checking and restoring blood flow, and tight glucose management. Red light therapy is studied as something you add on top of this, never as a replacement.

How Red Light Is Supposed to Help a Wound

The proposed mechanism is reasonable and grounded in cell biology, even if its size in real wounds is debated. Red light (roughly 630 to 660 nm) and near-infrared light (roughly 810 to 904 nm) are absorbed by a part of the cell's energy machinery called cytochrome c oxidase, inside the mitochondria. When this enzyme absorbs the light, cells can produce more ATP, the molecule that fuels repair.

Several downstream effects have been measured in lab and animal studies:

• More ATP and energy available to skin and immune cells
• A short burst of signaling molecules that nudges cells to divide and migrate into the wound
• Release of nitric oxide, which widens small blood vessels and may improve local blood flow
• Faster growth of new blood vessels (angiogenesis) and new connective tissue
• A calming effect on excess inflammation that can stall a chronic wound

These steps each address a real weakness in the diabetic foot: poor energy supply, poor circulation, and stalled repair. The biology is plausible. The open question is whether shining light on a human ulcer moves those levers enough to change whether and when the wound closes. For more on the circulation side of this, see our deep dive on red light therapy and circulation.

One detail matters for a foot wound specifically: depth. A diabetic foot ulcer is not a surface blemish; the tissue that needs to rebuild sits millimeters below the wound edge. Visible red light (630–660 nm) is absorbed quickly and acts mostly near the surface, while near-infrared light (810–904 nm) reaches deeper before it scatters. That physics is one reason several trials lean on infrared, and why some researchers suspect a wavelength studied for facial skin may not behave the same way on a deep, poorly perfused wound. If you want the underlying detail on how far each wavelength travels, our piece on how red light penetrates skin by wavelength lays out the depth charts.

The Human Evidence, Graded Honestly

This is where careful reading matters. The headline numbers from meta-analyses look encouraging, but the people who ran those analyses graded their own confidence as low or very low. Both things are true at once, and a responsible summary has to hold both.

The Cochrane Review: The Most Conservative Read

The Cochrane Collaboration sets a high standard for evidence and tends toward caution. Its 2017 review pooled 8 trials with 316 participants. Combining four of those studies (116 participants), phototherapy increased the share of wounds that fully healed compared with sham or no light, with a risk ratio of 1.57 (95% CI 1.08 to 2.28). In plain terms, roughly 65% of light-treated ulcers healed versus 37% of controls in those trials.

That sounds strong. But Cochrane rated the quality of evidence as low using the GRADE system, meaning the true effect could be quite different from the estimate. The reasons were small studies and a real risk of bias in how the trials were run and reported. Cochrane's bottom line: phototherapy may increase healing and reduce wound size, but large, well-designed trials are still needed to confirm it.

The Larger Meta-Analyses: Bigger Effect, Lower Confidence

A 2021 meta-analysis by Huang and colleagues went wider, pooling 13 randomized controlled trials and 413 patients. It found LLLT more than doubled the complete healing rate versus control, with a risk ratio of 2.10 (95% CI 1.56 to 2.83, P < .00001). It also reported faster reduction in ulcer area and shorter healing time. The wavelengths across the included studies ranged from 400 to 904 nm.

Here is the catch the authors themselves flagged: they graded the overall evidence as very low on the GRADE scale. The studies had imperfect designs, small samples, and a lot of statistical heterogeneity (the ulcer-area result had an I-squared of 92%, which is very high inconsistency). High heterogeneity means the trials disagreed with each other a lot, so the pooled average should be read with real caution.

A 2025 umbrella review, which is a review of the existing reviews and meta-analyses, reached a similar place. It concluded that PBM with various settings was effective at promoting ulcer healing compared with standard care or no light, but it stressed that the ideal wavelength, dose, and frequency are not standardized and that better trials are needed to lock down the right parameters.

A Snapshot of the Key Studies

What an Individual Trial Looks Like

A 2024 randomized trial tested home-based red LED, infrared LED, combined LED, and a control group over 12 weeks. Infrared LED produced the biggest reduction in ulcer area, with a large effect size, and individually applied red or infrared light tended to beat the combined approach. It is one well-run study with a small sample, so it is a useful signal rather than the final word. It does, though, line up with the broader pattern: near-infrared light may matter more than visible red for a wound that sits below the skin surface.

How to Read These Numbers Without Fooling Yourself

A risk ratio of 2.10 is the kind of figure marketers love to quote. It is real, but it comes with three big asterisks.

First, GRADE ratings of low or very low are warnings, not footnotes. They mean the published effect could shrink, vanish, or change with better studies. Photobiomodulation has a long history of impressive early results that get smaller as trial quality improves.

Second, publication bias is likely. Small wound-healing studies that find nothing often never get published. That tilts the pooled average upward. Several of the meta-analyses noted this concern.

Third, the protocols are all over the map. Wavelengths from 400 to 904 nm, different power levels, different session lengths, different numbers of sessions. When the recipe is not standardized, it is hard to know which version, if any, actually works. The honest summary is that red and near-infrared light is a plausible and promising adjunct with low-quality supporting evidence, not a proven treatment.

What a Treatment Protocol Looks Like in the Studies

If you read the trials, the protocols vary so much that "the protocol" does not really exist. Still, a rough picture emerges that is useful for setting expectations.

Most studies treated the ulcer a few times per week, often three sessions weekly, over a stretch of four to twelve weeks. Each session lasted from a couple of minutes to around ten or fifteen, depending on wound size and device power. Some used a laser probe held near the wound; others used an LED panel or cluster that covered the whole foot. The 2024 LED trial had patients apply light at home daily for twelve weeks, which is on the more intensive end.

The "dose" of light, measured in joules per square centimeter, ranged widely across studies, and that is part of why the results are so hard to compare. Too little light may do nothing; very high doses can, in theory, slow healing rather than help it, a quirk of photobiomodulation called the biphasic dose response. Because no single dose has been validated for diabetic foot ulcers, any protocol you encounter is best understood as one lab's educated guess, not a settled standard. This is exactly the standardization gap the 2025 umbrella review pointed to when it called for better trials.

The practical lesson: if a clinic or device maker quotes you an exact "proven" wavelength, power, and session schedule for healing a foot ulcer, treat that confidence with skepticism. The honest state of the field is that the recipe is still being worked out.

Cost and Access

Light therapy is cheap compared with most wound-care extras, which is a real part of its appeal. Many wound clinics that offer it fold it into a visit rather than billing it as a costly stand-alone procedure. Consumer LED panels and laser devices range from under a hundred dollars to well over a thousand, and a basic unit costs far less than a course of hyperbaric oxygen or a negative-pressure system.

Insurance coverage is inconsistent and usually depends on the device's clearance status and the clinical setting. A foot ulcer treated in a podiatry or wound-care practice has a better chance of coverage for any adjunct than a home gadget bought online. Do not assume reimbursement, and do not let a low price tempt you into skipping the clinic. The cost that matters most in a diabetic foot ulcer is not the device; it is the cost of a wound that does not heal.

How It Compares to Other Add-On Wound Therapies

If you are weighing options with a wound-care team, it helps to see where light therapy sits among the extras layered onto standard care.

The takeaway is not that light therapy is the best add-on. It is that light therapy is one of the cheapest and lowest-risk add-ons, which is exactly why researchers keep testing it even while the evidence stays thin. For the broader picture of light therapy across many wound types, see our red light therapy for wound healing evidence review.

A Word on Diabetic Neuropathy

Many people with foot ulcers also have diabetic peripheral neuropathy, the nerve damage that lets a wound form unnoticed in the first place. The light-therapy research for nerve symptoms is a separate body of evidence from the ulcer-healing research, and it has its own mixed picture. We cover it in detail in our red light therapy for diabetic neuropathy summary. The short version: do not assume a device studied for ulcers will fix nerve pain, or the reverse.

Safety: Generally Low Risk, With Real Caveats

Across the trials, red and near-infrared light therapy was well tolerated, and serious side effects were rare. The light does not produce meaningful heat at therapeutic doses, and there is no ionizing radiation, so it does not carry the cancer risk that the word "radiation" might suggest. For most people this is one of the safer therapies you can add.

That said, the diabetic foot is a special situation, and "low risk" is not "no risk."

• A foot ulcer is a medical emergency in slow motion. Never self-treat at home in place of seeing a wound-care clinician. A missed infection can cost a limb.
• Reduced sensation cuts both ways. Because neuropathy dulls feeling, you may not notice if a device runs hot or if skin is irritated. Have a provider supervise placement and timing.
• Active infection, exposed bone, or signs of spreading redness mean stop and seek urgent care, not more light.
• Eyes need protection if the device is bright; near-infrared is invisible but still intense.
• Photosensitizing medications (some antibiotics, certain other drugs) can change how skin reacts to light. Check with your pharmacist.

Light therapy is an add-on to a real wound-care plan, supervised by people who manage the ulcer, the circulation, the infection, and the blood sugar together.

Who This Is and Is Not For

It may be worth discussing with your wound-care team if you have a chronic diabetic foot ulcer that is healing slowly despite good offloading, debridement, and infection control, and you want a low-risk, low-cost therapy to add on. The evidence is weak but leans positive, and the downside is small when done under supervision.

It is probably not the right focus if your ulcer has not yet been properly offloaded, if there is untreated infection or poor blood flow, or if you are tempted to use a home device instead of clinical care. No amount of light fixes a wound that is still being crushed by body weight or starved of blood. Get the fundamentals right first; light therapy is the last brick, not the foundation.

It is not a home remedy for a foot ulcer. This is the one place we will be blunt. People have lost feet by managing serious wounds at home. If you have an open sore on a diabetic foot, that is a clinic visit today, not a gadget purchase.

The Bottom Line

Red and near-infrared light therapy has a believable mechanism and meta-analyses that show meaningfully higher healing rates when added to standard diabetic foot ulcer care. Those same analyses rate their own evidence as low or very low quality because the trials are small, inconsistent, and at risk of bias. Near-infrared light may have an edge over visible red for these deeper wounds, and the safety profile is reassuring. Treat it as a promising, inexpensive adjunct worth raising with your wound-care team, not as a proven cure and never as a substitute for the offloading, debridement, and infection control that actually drive healing.

Frequently Asked Questions

Does red light therapy actually heal diabetic foot ulcers?

The pooled trial data point in a positive direction. A 2021 meta-analysis of 13 RCTs found light therapy more than doubled the complete healing rate (risk ratio 2.10), and the 2017 Cochrane review found a similar boost (risk ratio 1.57). But both groups rated the quality of that evidence as low or very low because the studies were small and inconsistent. So the honest answer is that it may help as an add-on, and it is not yet proven.

Is red light therapy a replacement for standard wound care?

No. Every credible study adds light therapy on top of standard care, never in place of it. The proven foundations are pressure offloading, debridement, infection control, restoring blood flow, and blood sugar management. Light therapy is a possible extra, not a substitute, and using it alone for a serious ulcer is dangerous.

What wavelength works best for diabetic foot ulcers?

The research has not settled this, which is one of the field's biggest weaknesses. Studies used wavelengths anywhere from 400 to 904 nm. A 2024 RCT found infrared LED produced the largest reduction in ulcer area, beating visible red and combined light, which fits the idea that near-infrared penetrates deeper. But no single setting has been validated across enough good trials to call it the standard.

Can I treat my own foot ulcer at home with a red light device?

You should not manage a diabetic foot ulcer on your own. These wounds can hide infection that spreads fast, and neuropathy means you may not feel the warning signs. An open sore on a diabetic foot needs a clinician now. If a provider approves light therapy as part of your plan, a home device may be used under their supervision, but it never replaces the clinic.

Is red light therapy safe for people with diabetes?

In the trials, it was well tolerated with rare side effects, no meaningful heat, and no ionizing radiation. The main cautions are specific to the diabetic foot: reduced sensation can hide problems, active infection means stop and seek care, eyes should be protected from bright light, and a few medications increase light sensitivity. Used under medical supervision, it is one of the lower-risk add-on therapies.

This article is for general information only and is not medical advice. A diabetic foot ulcer is a serious condition that requires prompt, hands-on care from a qualified clinician. Always consult your healthcare provider before starting or changing any treatment.

Sources

• Phototherapy for treating foot ulcers in people with diabetes (Cochrane Review, 2017) — PMID 28657134
• The effect of low-level laser therapy on diabetic foot ulcers: a meta-analysis of randomised controlled trials (Huang et al., 2021) — PMID 33751853
• Photobiomodulation using red and infrared LED for the healing of diabetic foot ulcers: a randomized clinical trial (2024) — PMID 39382587
• Effects and parameterization of low-level laser therapy in diabetic ulcers: an umbrella review (2025) — PMID 39982518
• Low-level laser therapy as an adjunct to conventional therapy in diabetic foot ulcers (2017) — PMID 27896528
• Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update) — PMID 37226568
• PubMed search: low-level laser therapy and diabetic foot ulcers